Everyone on GV's life sciences team came in as a physician, scientist, or operator with aspirations to move the healthcare system forward. As a group, we want to change how healthcare is delivered, make more impactful drugs, and improve all aspects of people's access to care.
We started investing in healthcare in 2009 and look at everything through the lens of whether an investment will improve patient outcomes. We have backed therapeutics, diagnostics, medical devices, and health tech startups at the earliest stages. These transformative companies include Verve Therapeutics, ROME Therapeutics, Prime Medicine, Flatiron Health, Aspire Health, One Medical, and many others.